G protein-coupled receptors (GPCRs) transduce pleiotropic intracellular signals in mammalian cells. Here, we report that some antagonists of β adrenergic receptors (βARs) such as β-blocker carvedilol and alprenolol activate β 2 AR at nanomolar concentrations, which promote G protein signaling and cAMP/PKA activity without action of G protein receptor kinases (GRKs). The cAMP/PKA signal is restricted within the local plasma membrane domain, leading to selectively enhance PKA-dependent augment of endogenous L-type calcium channel (LTCC) activity but not AMPA receptor in hippocampal neurons. Moreover, we have engineered a mutant β 2 AR that lacks serine 204 and 207 in the catecholamine binding pocket. This mutant can be preferentially activated by carvedilol but not the orthosteric agonist isoproterenol.
Introduction
GPCRs often signal not only through canonical G proteins but also through noncanonical G protein-independent signaling, frequently via G protein receptor kinases (GRKs) and β-arrestins (1, 2) . One of the universal features of GPCRs is that they undergo ligand-induced phosphorylation at different sites by either GRKs or second messenger dependent protein kinases such as protein kinase A (PKA). The phosphorylated GPCRs thus may present distinct structural features that favor receptor binding to different signaling partners, engaging distinct downstream signaling cascades (3) (4) (5) . Some ligands can differentially activate a GPCR via a phenomenon known as functional selectivity or biased signaling (6, 7) . For example, stimulation of β 2 -adrenergic receptor (β 2 AR), a prototypical GPCR involved in memory and learning in the central nervous system (CNS) and regulation of metabolism and cardiovascular function, promotes phosphorylation by both GRKs and PKA (8) (9) (10) (11) . We on the phosphorylation of β 2 AR at its PKA and GRKs sites, respectively (12, 27, 28) .
We found that various β-blockers including alprenolol (ALP), carvedilol (CAR), propranolol (PRO) and CGP12177 (177) were able to stimulate phosphorylation of β 2 AR at PKA sites expressed in HEK293 cells, similar to the βAR agonist isoproterenol (ISO) (Fig. 1a) . In contrast, other β-blockers, i.e., ICI118551 (ICI), timolol (TIM) and metoprolol (MET), were not able to do so (Fig. 1a) . The ligand-induced phosphorylation of β 2 AR was blocked by β 2 AR-specific antagonist ICI but not β 1 AR-specific antagonist CGP20712A (CGP) (Fig. 1b,c) . We chose CAR and ALP for further study. We found that CAR and ALP promoted phosphorylation of β 2 AR by PKA even at nanomolar concentrations ( Fig. 2a,b) , which was paralleled by concentration-dependent increases in phosphorylation of ERK (Supplemental Fig. 1 ).
The roles of β 2 AR and PKA in this phenomenon were confirmed by inhibition of β 2 AR with ICI and inhibition of PKA with H89, respectively ( Fig. 2c,d) . In contrast, those β-blockers induced at best minimal increases in phosphorylation of β 2 AR at GRK sites and only at high concentrations, consistent with previous report (29) ( Fig. 1a and Supplemental Fig. 1,2) . As positive control, the βAR agonist ISO promoted robust increases in both PKA and GRK phosphorylation of the receptors at different concentrations ranging from nanomolar to micromolar (Fig. 1,2 and Supplemental Fig. 1,2) . In the CNS, β 2 AR emerges as a prevalent postsynaptic norepinephrine effector at glutmatergic synapses (30-33). Consistent with the data from HEK293 cells, we found that β-blockers CAR and ALP activated β 2 AR and promoted phosphorylation of the receptor by PKA in hippocampal neurons (Fig. 4a) . Together, these data suggest that certain β-blockers selectively promote PKA phosphorylation of β 2 AR in HEK293 and primary hippocampal neurons.
Carvedilol and alprenolol promote Gsα recruitment to β 2 AR and increase locally restricted cAMP signal.
The western blot data on PKA phosphorylation of β 2 AR indicates a stimulation of the receptor-mediated Gs/AC/cAMP pathway by these β-blockers. We measured ligand-induced Gsα recruitment to β 2 AR with an in situ proximity ligation assay (PLA), which allows direct visualization and quantification of protein-protein interactions. We showed that ISO, CAR and ALP were able to increase the PLA signals between β 2 AR and Gsα, indicating recruitment of Gsα to β 2 AR (Fig. 3a) . As control, TIM had no effect on the recruitment of Gsα to β 2 ARs. The role of Gs/AC in CAR-induced PKA phosphorylation of β 2 AR was further validated by AC-specific inhibition with 2',3'-dideoxyadenosine (ddA, Supplemental Fig. 3) . These data indicate that CAR and ALP are able to stimulate β 2 AR-Gs signal to increase PKA phosphorylation of the receptor. β-blockers have been thought to generally block β 2 AR-induced cAMP signal. We hypothesized that the cAMP signal induced by β-blockers is restricted to local plasma membrane domains containing activated receptor, which is not detectable with traditional cAMP assays likely due to limited sensitivity. We applied highly sensitive FRET-based biosensor ICUE3 to detect the dynamics of cAMP signal in living cells (34, 35) . The full agonist ISO promoted cAMP signal in HEK293 cells while all β-blockers failed to do so ( Fig. 3b) , in agreement with the classic definition of β-blockers. However, when cells were treated with non-selective phosphodiesterase (PDE) inhibitor IBMX, CAR, ALP and CGP12177 were able to induce small but significant cAMP signal in HEK293 cells ( Fig. 3c) , indicating a role of PDE in suppressing and restricting the distribution of cAMP in the cells. When β 2 AR was exogenously expressed in HEK293 cells, CAR and ALP were able to induce cAMP signal in HEK293 cells even without PDE inhibition (Supplemental Fig. 4) , probably due to insufficient cAMP-hydrolytic activity of endogenous PDEs to counter cAMP production induced from overexpressed β 2 AR. We then engineered a targeted cAMP biosensor by fusing the biosensor ICUE3 to the C-terminus of β 2 AR (β 2 AR-ICUE3), aiming to detect increases of cAMP within the local domain of activated β 2 AR. CAR and ALP promoted cAMP activity within the immediate vicinity of the receptor. CAR and ALP promoted cAMP signals within the local domain of activated β2AR even at nanomolar concentrations ( Fig. 3d,e ). The local increases of cAMP were abolished by inhibition of β 2 AR with ICI or inhibition of ACs with ddA ( Fig. 3e) . These data confirm that CAR and ALP promote cAMP/PKA activity within the local domain of activated β 2 AR, in contrast to the broad distribution of cAMP/PKA activities induced by ISO in the cells.
Carvedilol augments the endogenous β 2 AR-dependent PKA phosphorylation of

Ca V 1.2 and its channel activity in hippocampal neurons.
The local cAMP signals possess the potential to selectively regulate downstream effectors in receptor complexes or within the vicinity of activated receptors. In the CNS, β 2 AR emerges as a prevalent postsynaptic norepinephrine effector at glutmatergic synapses, where β 2 AR functionally interacts with AMPA receptor (AMPAR) and L-type Ca 2+ channel (LTCC) Ca V 1.2, and regulates neuronal excitability and synaptic plasticity (30-33). CAR and ALP, but not TIM significantly increased PKA phosphorylation of S1928 and S1700 of central α 1 1.2 subunit of Ca V 1.2 in hippocampal neurons when both β 2 AR and LTCC were endogenously expressed ( Fig.   4a ). However, CAR and ALP failed to promote phosphorylation of the AMPAR subunit GluA1 on its PKA site serine 845 ( Fig. 4b) . Like Ca V 1.2, AMPARs are associated with β 2 AR, Gs, AC and PKA (32-35). These results indicate high selectivity in targeting downstream substrates by this β-blocker-induced signaling in hippocampal neurons.
Meanwhile, the CAV and ALP-induced PKA phosphorylation of LTCC were blocked by β 2 AR inhibitor ICI, AC inhibitor ddA, and PKA inhibitor H89, but not CaMKII inhibitor KN93, validating the activation of β 2 AR-cAMP-PKA pathway (Fig. 4c) . We then examined the effects of CAR on PKA-dependent activation of LTCC Ca V 1.2 channels using single channel recordings in hippocampal neurons. Consistent with the phosphorylation data, CAR but not TIM significantly increased open probabilities of endogenous Ca V 1.2 in hippocampal neurons ( Fig. 4d,e ). These data indicate that CAR promotes local cAMP/PKA activities for selective augmentation of LTCC activities in neurons.
Carvedilol but not isoproterenol selectively activates a mutant β 2 AR to augment LTCC activity in neurons.
Structure-functional analyses of β 2 AR have previously revealed distinct residues important for binding to catecholamines and β-blockers (36) (37) (38) (39) . We hypothesized that mutation of Ser204 and Ser207 sites within β 2 AR binding pocket would abolish receptor hydrogen bonds with the catecholamine phenoxy moieties, thus reducing binding affinity to agonist ISO while having no effect on β-blocker binding ( Fig. 5a) .
Such a mutant β 2 AR could thus be selectively activated by CAR. We co-expressed the cAMP biosensor ICUE3 together with either wild-type (WT) β 2 AR or mutant S204A/S207A β 2 AR in MEF cells lacking endogenous β 1 AR and β 2 AR (DKO) to detect receptor signaling induced by different ligands. The mutant S204A/S207A β2AR induced a moderate cAMP signal at high but not low concentrations of ISO ( Fig. 5b) .
In contrast, after stimulation with CAR, the β 2 AR mutant S204A/S207A promoted significant cAMP signals at nanomolar concentrations; the overall concentration response curve was similar to those induced by WT β 2 AR ( Fig. 5b) . Accordingly, the ISO-induced PKA phosphorylation of β 2 AR S204A/S207A mutant was selectively abolished at nanomolar concentrations. At higher concentrations, ISO was able to induce reduced PKA phosphorylation of the β 2 AR S204A/S207A mutant when compared to WT β2AR, consistent with the data of cAMP signals ( Fig. 5c) . Meanwhile, ISO failed to induce GRK phosphorylation of β 2 AR S204A/S207A mutant at different concentrations ( Fig. 5c ). In comparison, CAR induced equivalent PKA phosphorylation of β 2 AR WT and S204A/S207A mutant at different concentrations ( Fig. 5d) . These data suggest that CAR, but not ISO selectively activates the S204A/S207A mutant β 2 AR at nanomolar concentrations. We then tested the effects of β 2 AR S204A/S207A mutant on LTCC channel activity after treatment with CAR in hippocampal neurons. In DKO neurons expressing the mutant S204A/S207A β 2 AR, CAR, but not ISO (30 nM) promoted PKA phosphorylation of LTCC α 1 1.2 ( Fig. 6a and Supplemental Fig. 5 ). In agreement, CAR, but not ISO significantly increased open probabilities of Ca V 1.2 (Fig. 6b,c) . Together, CAR but not ISO selectively activates the S204A/S207A mutant β 2 AR at low concentrations and increases channel opening probabilities.
Discussion
In a classic view, agonist stimulation promotes both PKA and GRK phosphorylation of activated GPCRs. In this study using a combination of highly sensitive tools such as engineered FRET-based cAMP sensors and single channel recording together with detection with phospho-specific antibodies, we show that some β-blockers can promote activation of β 2 AR and selectively transduce G protein/cAMP/PKA signaling but not GRK signaling. The β 2 AR-induced cAMP signal is highly restricted to the local domain, which selectively promotes activation of receptor-associated LTCC but not AMPAR in primary hippocampal neurons. Moreover, we have engineered a mutant β 2 AR that is selectively activated by β-blockers but not by catecholamines at low concentration. This study defines CAR and ALP as Gs-biased partial agonists of βAR for spatially highly restricted cAMP/PKA signaling to Ca V 1.2 in neurons.
PKA-mediated phosphorylation is thought to play critical roles in heterologous desensitization of GPCRs and in receptor switching from Gs to Gi coupling (40, 41) , whereas GRK-mediated phosphorylation is implicated in β-arrestin recruitment and β-arrestin-dependent ERK activation (13) (14) (15) (16) (17) (18) . We have recently characterized that PKA and GRKs phosphorylate distinct subpopulations of β 2 AR in a single fibroblast or neuron (12) . While GRK phosphorylation of β 2 AR is only observed at high concentrations of agonists, PKA phosphorylation can be induced with minimal doses of agonist (12, 27, 28, 42) . Here, our data show CAR does not promote GRK phosphorylation at low concentrations and induces a slow and minimal GRK effect at high concentrations when compared to those induced by ISO. The CAR-induced GRK effects are minimally related to the PKA effects. Previously, CAR has been recognized as a biased β-blocker that preferentially activates β-arrestin/ERK pathways (29, 43) . Despite the prominent role of GRK phosphorylation in full agonist ISO-induced β 2 AR-β-arrestin/ERK signaling, our data clearly indicate that GRK phosphorylation of β 2 AR is not necessary for CAR-induced activation of ERK, consistent with a recent study showing a distinct general mechanism of β-arrestin activation that does not require the GRK-phosphorylated tail of different GPCRs (44) .
Meanwhile, other studies show that in the absence of all G proteins, GPCRs fail to transduce β-arrestin/ERK signaling (45) . These data indicate the necessity of G proteins in GPCR-induced arrestin activation. In our study, we observed that a concentration-dependent correlation between PKA phosphorylation of β 2 AR with ERK activity induced by β-blockers, suggesting the potential role of Gs and PKA in CAR-induced β 2 AR-β-arrestin/ERK signaling are overlooked. In comparison, Gi is not required for CAR-induced β 2 AR/β-arrestin signaling even though CAR induces Gi recruitment to β 1 AR for transducing β 1 AR/β-arrestin signaling (46). Moreover, our results are also in line with a recent report that activation of β 2 AR with as low as femtomolar concentrations of ligands causes sustained ERK signaling (47), further support a PKA but GRK-dependent mechanism in GPCR-induced ERK activation.
Future studies will help us understand how ligand-induced GPCRs utilize distinct mechanisms in activating β-arrestin/ERK pathway.
Engineered GPCRs have been widely applied in investigating structural and biological processes and behaviors by precisely controlling specific GPCR signaling branches (46). Previous mutagenesis studies have shown that β 2 AR with S204/207A mutation loses binding to adrenaline but still binds with several β-blockers including ALP (37) .
Based on this and recent advances in βAR structures with agonists and β-blockers (38, 39) , we have generated a S204/207A mutant that bestow β 2 AR with the ability to be selectively activated by β-blockers such as CAR and to transduce cAMP/PKA signaling. At nanomolar concentrations, while ISO fails to stimulate PKA phosphorylation of the S204/207A mutant β 2 AR, the mutant receptor still retains CAR-induced stimulation of PKA-phosphorylation of the receptor. The CAR-induced activation of mutant β 2 AR triggers the β 2 AR/Gs/cAMP/PKA signaling pathway and selectively targets downstream effectors in primary hippocampal neurons.
Interestingly, the S204/207A β2AR mutant is not only refractory to its agonists but also completely lost both ISO-and CAR-induced GRK-phosphorylation of β 2 AR. Further studies comparing this mutant with previous reported β 2 AR-TYY and Y219A mutants that lack Gs and GRKs coupling, respectively (18, 47) , will facilitate the analysis of the physiological relevance of Gs/cAMP/PKA-dependent and GRK-dependent signaling pathways and enable researchers to explore β-arrestin/ERK pathway devoid of individual signaling branches.
β-blockers are a standard clinical treatment in a broad range of diseases. Many β-blockers possess intrinsic sympathomimetic activities (19, 20) , which are problematic due to the side effects through stimulation of βARs (19, 20) , a feature that limits the clinical utility of the drugs. Here, we show that β-blockers promote activation of β 2 AR by recruiting Gs that selectively transduces cAMP/PKA signal but not GRK signal. Meanwhile, binding of β-blockers to β 1 AR has been shown to enhance cAMP levels locally by dissociating a β 1 AR-PDE4 complex, thereby reducing the local cAMP-hydrolytic activity (48), β 1 AR and β 2 AR thus could utilize different mechanisms for β-blocker-induced signaling. Another interesting observation is that the β-blocker-induced β 2 AR-cAMP signal is sufficient to promote PKA phosphorylation of both β 2 AR and the receptor-associated Ca V 1.2 of LTCC, but not another substrate, the AMPAR GluA1 subunit. Both LTCC and AMPAR are shown to associate with the β 2 AR in hippocampal neurons (30-33). Therefore, the preference of one local membrane target over another local target indicates a highly restricted nature of the cAMP-PKA activities, potentially dependent on the recently identified distinct subpopulations of β 2 AR and associated signaling molecules in the neurons (12) .
Nevertheless, the PKA phosphorylation leads to augmentation of LTCC activity, potentially contributing to the neuronal toxicities. Therefore, activation of GPCR at low ligand concentrations should be taken into consideration when designing and screening new therapeutic drugs.
Methods
Plasmids
DNA constructs expressing FLAG-tagged human β 2 AR (FLAG-β 2 AR) and HA-tagged rat L-type calcium channel (LTCC) α 1 1.2 were described before (12) . FLAG-tagged human β 2 AR with S204/207A double mutations (FLAG-mutant) was generated by Gibson assembly method (Thermo Fisher) using FLAG-β 2 AR and synthetic gBlocks with the double mutations as templates (Integrated DNA Technologies). FRET biosensor ICUE3 was described before (34). To make the β 2 AR-ICUE3 fusion biosensor, ICUE3 was fused to the C-terminal of FLAG-β 2 AR with Gly-Ser linker.
HA-Gsα was made by replacing CFP with HA tag, using Gsα-CFP as template (a gift from Dr. Catherine Berlot, Addgene plasmid # 55793).
Antibodies and Chemicals
Mouse monoclonal antibodies against β 2 AR at serine 261/262 (clone 2G3) and at 
Cell Culture and Transfection
Human embryonic kidney HEK293 cells were from American Type Culture Collection (ATCC) and were maintained in Dulbecco's modified Eagle medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS, Sigma). HEK293 cells stably expressing FLAG-β 2 AR was from previous study (35) . HEK293 cells stably expressing FLAG-mutant β 2 AR was generated in this study. Briefly, cells transfected with β 2 AR-mutant were selected by G418 resistance (Corning) and cell clones were obtained by limiting serial dilution, monoclonal cells were analyzed by western blots and the one with comparable β 2 AR expression to FLAG-β 2 AR stable cells was chosen.
Mouse embryonic fibroblasts (MEFs) from β 1 AR/β 2 AR double knockout (DKO) mouse was described in previous study (50) and were maintained in DMEM supplemented with 10% FBS. Primary mouse hippocampal neurons were isolated and cultured from P0-P1 early postnatal DKO mouse pups, and primary rat hippocampal neurons were prepared from E17-E19 embryonic rats using methods described previously (51, 52) . HEK293 cells were transfected with plasmids using polyethylenimine according to manufacturer's instructions (Sigma). Neurons were transfected by the Ca 2+ -phosphate method (53) . Briefly, cultured neurons on 6-10 DIV were switched to pre-warmed Eagle's minimum essential medium (EMEM, Thermo Fisher) supplemented with GlutaMax 1 hour before transfection, conditioned media were saved. DNA precipitates were prepared by 2x HBS (pH 6.96) and 2 M CaCl 2 . After incubation with DNA precipitates for 1 hour, neurons were incubated in 10% CO 2 pre-equilibrium EMEM for 20 minutes, then replaced with conditioned medium and cultured in 5% CO 2 incubator until use.
Confocal Microscopy Imaging
Rat hippocampal neurons were transfected with FLAG-β 2 AR on 10 DIV, treated for 5 minutes with 10 nM or 1 μM indicated drugs on 12 DIV. Mouse DKO hippocampal neurons were transfected with FLAG-β 2 AR or FLAG-mutant and HA-α 1 1.2 at 1:1 ratio on 6-8 DIV, and stimulated with indicated drugs and times 24 hours after transfection.
Treated cells were fixed, permeabilized, and co-stained with indicated antibodies with a final concentration of 1 μg/ml for each antibody, which were revealed by a 1:1000 dilution of Alexa fluor 488 conjugated goat anti-rabbit IgG or Alexa fluor 594 conjugated goat anti-mouse IgG, respectively. Fluorescence images were taken by Zeiss LSM 700 confocal microscope with a 63×/1.4 numerical aperture oil-immersion lens.
Proximity ligation assay
HEK293 cells growing on poly-D-lysine coated coverslips were transfected with FLAG-β 2 AR or FLAG-mutant, HA-Gsα and pEYFP-N1 at 8:1:1 ratio. 24 hours after transfection, cells were serum-starved 2 hours, treated 100 nM indicated drugs for 5 minutes. Following stimulation, cells were fixed, permeabilized, and co-stained with anti-β 2 AR antibody (1:100 dilution) from rabbit in conjunction with anti-HA antibody (1:1000 dilution) from mouse. The proximity ligation reaction was performed according to the manufacturer's protocol using the Duolink in situ detection orange reagents (Sigma). Images were recorded with Zeiss LSM 700 confocal microscope with a 63×/1.4 numerical aperture oil-immersion lens. To quantify the PLA signals, the number of red fluorescent objects in each image was quantified using the Squassh plug-in for ImageJ software (54) , and divided by the number of transfected cells.
Fluorescence resonance energy transfer (FRET) measurement
FRET measurement was performed as previously described (35) . Briefly, HEK 293 cells were transfected with ICUE3 or β 2 AR-ICUE3, DKO MEFs were co-transfected with ICUE3 and FLAG-β 2 AR or FLAG-mutant. Cells were imaged on a Zeiss Axiovert 200M microscope with a 40×/1.3 numerical aperture oil-immersion lens and a cooled CCD camera. Dual emission ratio imaging was acquired with a 420DF20 excitation filter, a 450DRLP diachronic mirror, and two emission filters (475DF40 for cyan and 535DF25 for yellow). The acquisition was set with 0.2 second exposure in both channels and 20 second elapses. Images in both channels were subjected to background subtraction, and ratios of yellow-to-cyan were calculated at different time points.
Western blot
HEK293 cells stably expressing FLAG-β 2 AR or FLAG-mutant were serum-starved for 2 hours and treated with indicated drugs and times, then harvested by lysis buffer (10 mM Tris pH 7.4, 1% NP40, 150 mM NaCl, 2 mM EDTA) with protease and phosphatase inhibitor cocktail. Rat hippocampal neurons on 10-14 DIV were treated with indicated drugs and times, then harvested by lysis buffer (10 mM Tris pH 7.4, 1% TX-100, 150 mM NaCl, 5 mM EGTA, 10 mM EDTA, 10% glycerol) with protease and phosphatase inhibitor cocktail. Protein samples were analyzed by Western blot using antibodies as indicated at a 1:1000 dilution and signals were detected by Odyssey scanner (Li-cor). Uncropped scans are presented in Supplemental Fig. 6 . 
Cell-attached Patch Clamp Electrophysiology
Statistical analysis
Data were analyzed using GraphPad Prism software and expressed as mean ± s.e.m.
Differences between two groups were assessed by appropriate two-tailed unpaired Student's t-test or nonparametric Mann-Whitney test. Differences among three or more groups were assessed by One-way ANOVA with Tukey's post hoc test. P < 0.05 was considered statistically significant.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
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